Crystallization and preliminary crystallographic studies of ribosome recycling factor from Escherichia coli

Jungmin Yun; Wookhyun Kim; Sung Chul HaSoo-Hyun EomSe Won SuhKyeong Kyu Kim

首页> 外文期刊>Acta crystallographica.Section D. Biological crystallography >Crystallization and preliminary crystallographic studies of ribosome recycling factor from Escherichia coli

【24h】

Crystallization and preliminary crystallographic studies of ribosome recycling factor from Escherichia coli

机译：结晶和初步的晶体从研究核糖体循环因素大肠杆菌

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Ribosome recycling factor (RRF) catalyzes the disassembly of a termination complex during the final stage of protein synthesis. RRF from Escherichia coli has been crystallized with PEG 400 as precipitant at 287 K. The crystal belongs to the trigonal space group P3_121 (or P3_221), with unit-cell parameters a = b = 48.08, c = 141.67 A. Native data were collected from a frozen crystal to a resolution of 3.0 A on a Cu Kα rotating-anode X-ray source.

机译：核糖体(RRF)催化循环因素拆卸期间终止复杂蛋白质合成的最后阶段。大肠杆菌结晶了400年作为沉淀剂在287 K。三角形的空间群P3_121(或P3_221),晶胞参数a = b = 48.08, c =141.67。冻晶体铜3.0的决议Kα旋转阳极x射线源。

著录项

来源
《Acta crystallographica.Section D. Biological crystallography》 |2000年第1期|84-85|共2页
作者
Jungmin Yun; Wookhyun Kim; Sung Chul HaSoo-Hyun EomSe Won SuhKyeong Kyu Kim;
展开▼
作者单位

Department of Chemistry, College of Natural Sciences, Seoul National University, Seoul 151-742, South Korea;

Plant Molecular Biology and Biotechnology Research Center, Gyeongsang National University, Chinju 660-701, South Korea;

Department of Life Science, Kwangju Institute of Science and Technology, Kwangju 500-712, South Korea;

展开▼
收录信息
原文格式 PDF
正文语种英语
中图分类
关键词
Escherichia coli; ribosome releasing factor; Crystallization;

机译：大肠杆菌,核糖体释放结晶的因素;

相似文献

外文文献
中文文献
专利

1. Preliminary Studies on Base Substitutions and Repair of DNA Mismatch Damage Stimulated by Low Energy N+ Ion Beam Implantation in Escherichia coli [J] . 谢传晓, 郭金华, 程备久, 等离子体科学和技术（英文版） . 2003,第001期
2. A preliminary study on the cloning and expression of human papiilomavirus type 18 E6 gene in Escherichia coli [J] . 文维延, 徐钤中国人民解放军军医大学学报：英文版 . 1991,第001期
3. Effects of metabolic engineering on downstream processing operational cost and energy consumption: the case of Escherichia coli Escherichia coliEscherichia coli 's's glycerol conversion to succinic acid [J] . Tafur Rangel Albert Enrique, Camelo Valera Laura Carolina, Gómez Ramírez Jorge Mario, Journal of Chemical Technology & Biotechnology . 2018,第7期

机译：代谢工程对下游加工运营成本和能源消耗的影响： escherichia coli < fi xmlns =“http://www.wiley.com/namespace/wiley”> escherichia coli escherichia coli 's < / fi>对琥珀酸的甘油转化为琥珀酸
4. Fis protein forms DNA topological barriers to confine transcription‐coupled DNA supercoiling in Escherichia?coli Escherichia?coli [J] . Dages Samantha, Zhi Xiaoduo, Leng Fenfei FEBS letters. . 2020,第5期

机译：FIS蛋白形成DNA拓扑屏障，在大肠杆菌中限于大肠杆菌（Coli Escherichia）（Coli Escherichia）
5. Taxadiene‐5α‐ol is a minor product of CYP725A4 when expressed in Escherichia coliEscherichia coli [J] . Sagwan‐Barkdoll Laxmi, Anterola Aldwin M. Biotechnology and Applied Biochemistry . 2018,第3期

机译：TaxIniene-5α-OL是CYP725A4的次要产品，当在 escherichia coli eScherichia coli

6. A Preliminary Study on Recyclability of Mixed Plastic Wastes Recovered from Urban Collection [C] . R. Ferraioli, L. Incarnato, L. Di Maio International Symposium on Materials Science and Engineering;International Conference on Advanced Materials and Engineering Structural Technology . 2021

机译：A Preliminary Study on Recyclability of Mixed Plastic Wastes Recovered from Urban Collection

7. Engineering in Vivo Sulfation in Escherichia Coli for the Complete Biosynthesis of Sulfated Glycosaminoglycans [D] . Badri, Abinaya. 2020

机译：Escherichia Coli的体内硫化工程，硫酸化糖胺聚糖的完整生物合成

8. Measures used to assess the burden of ESBL-producing Escherichia coli infections in humans: a scoping review [O] . Kathryn L McDonald, Sarah Garland, Carolee A Carson, 2021

机译：用于评估人类Escherichia Coli感染的Esbl- eScherichia Coli感染的措施：范围审查

9. Studies of the recombinant plasmids carrying the adh mutation of escherichia coli. [O] . 1994

机译：studies of the recombinant plasmids carrying the adh mutation of escherichia coli.

10. Effect of the Method of Preparing Monochloramine upon Inactivation of MS2Coliphage, 'Escherichia coli', and 'Klebsiella pneumoniae' [R] . Berman, D., Sullivan, R., Hurst, C. J. 1991

机译：制备一氯胺的方法对ms2Coliphage，'Escherichia coli'和'Klebsiella pneumoniae'灭活的影响

1. Crystallization and Preliminary Crystallographic Studies of Cucurmosin 2, a Ribosome-inactivating Protein from the Sarcocarp of Cucurbita moschata [J] . HOU Xiao-Min ,CHEN Ming-Huang ,XIE Jie-Ming . 结构化学 . 2009,第002期

2. Crystallization and Preliminary Crystallographic Studies of Luffaculin 1, a Ribosome-inactivating Protein from the Seeds of Luffa Acutangula [J] . HOU ,Xiao-Min ,CHEN . 结构化学 . 2006,第009期

3. Crystallization and Preliminary Crystallographic Studies of Luffaculin 1, a Ribosome-inactivating Protein from the Seeds of Luffa Acutangula [J] . HOU Xiao-Min ,CHEN Ming-Huang ,XIE Jie-Ming . 结构化学 . 2006,第009期

4. Escherichia coli厌氧降解TNT的研究 [C] . 金若菲 ,陈琛 ,周集体 . 第五届全国环境化学大会会议 . 2008

5. Correlative factors of kyphosis angle reduction of osteoporotic vertebral Correlative factors of kyphosis angle reduction of osteoporotic vertebral compression fractures with kyphoplasty:A single center retrospective study. compression fractures with kyphoplasty:A single center retrospective study. [A] . Balaara Augustine Balaara Augustine . 2016

1. 一种大肠杆菌Escherichia coli ETEC BE-311菌株及其应用 [P] . 中国专利： CN112625989B . 2022-05-17

2. 大肠杆菌Escherichia coli ETEC BE-311-faeG及应用 [P] . 中国专利： CN112522172B . 2022-05-17

3. GENE-THERAPEUTIC DNA VECTOR BASED ON THE GENE-THERAPEUTIC DNA VECTOR GDTT1_8NAS12, CARRYING THE TARGET GENE SELECTED FROM A GROUP OF GENES DDC, IL10, IL13, IFNB1, TNFRSF4, TNFSF10, BCL2, HGF, IL2 TO INCREASE THE EXPRESSION LEVEL OF SAID TARGET GENES, A METHOD FOR PRODUCTION AND USE THEREOF, A STRAIN ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-DDC OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-IL10 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-IL13 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-IFNB1 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-TNFRSF4 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-TNFSF10 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-BCL2 OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-HGF OR ESCHERICHIA COLI JM110-NAS/GDTT1_8NAS12-IL2, CARRYING A GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, A METHOD FOR INDUSTRIAL PRODUCTION OF A GENE-THERAPEUTIC DNA VECTOR [P] . 外国专利： RU2734726C1 . 2020-10-22

机译：基于基因治疗DNA矢量GDTT1_8NAS12的基因治疗DNA矢量，携带从一组基因中选择的目标基因DDC，IL10，IL13，IFNB1，TNFRSF4，TNFSF10，BCL2，HGF，IL2可以增加表达水平基因，一种生产和使用其的方法，应变大肠埃希氏菌JM110-NAS / GDTT1_8NAS12-DDC或大肠埃希氏菌JM110-NAS / GDTT1_8NAS12-IL10或大肠埃希氏菌JM110-NAS / GDTT1_8NAS12-IL13或大肠埃希氏菌COLI JM110-NAS / GDTT1_8NAS12-IL13 IFNB1或ESCHERICHIA COLI JM110-NAS / GDTT1_8NAS12-TNFRSF4或ESCHERICHIA COLI JM110-NAS / GDTT1_8NAS12-TNFSF10或ESCHERICHIA COLI JM110-NAS / GDTT1_8NAS12-BCL2或ESCHERICHIA COLI JM110-NAS / GDTT1_8NAS12 IL2，携带基因治疗性DNA载体，其生产方法，工业生产基因治疗性DNA载体的方法

4. GENE-THERAPEUTIC DNA-VECTOR BASED ON THE GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING THE TARGET GENE SELECTED FROM THE SOD1, SOD2, SOD3, CAT GENE GROUP TO INCREASE THE LEVEL OF EXPRESSION OF THESE TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, ESCHERICHIA COLI SCS110-AF/VTVAF17-SOD1 STRAIN, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-SOD2, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-SOD3, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-CAT, CARRYING A GENE-THERAPEUTIC DNA VECTOR, A METHOD FOR PRODUCTION THEREOF, A METHOD FOR INDUSTRIAL PRODUCTION OF A GENE-THERAPEUTIC DNA VECTOR [P] . 外国专利： RU2731515C2 . 2020-09-03

机译：基于基因治疗DNA载体VTVAF17的基因治疗DNA载体，携带从SOD1，SOD2，SOD3和CAT基因组中选择的靶基因，以增加这些靶基因的表达水平，生产和使用方法，ESCHERICHIA COLI SCS110-AF / VTVAF17-SOD1应变或ESCHERICHIA COLI SCS110-AF / VTVAF17-SOD2或ESCHERICHIA COLI SCS110-AF / VTVAF17-SOD3或ESCHERICHIA COLI SCS110-AF / VTVAF17-CAT，携带基因-THERA DNA矢量，其生产方法，工业生产基因治疗DNA矢量的方法

5. GENE-THERAPEUTIC DNA-VECTOR BASED ON GENE-THERAPEUTIC DNA-VECTOR VTVAF17, CARRYING TARGET GENE SELECTED FROM GROUP OF GENES KRT5, KRT14, LAMB3, COL7A1, TO INCREASE LEVEL OF EXPRESSION OF THESE TARGET GENES, METHOD FOR PRODUCTION AND USE THEREOF, STRAIN ESCHERICHIA COLI SCS110-AF/VTVAF17-KRT5, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-KRT14, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-LAMB3, OR ESCHERICHIA COLI SCS110-AF/VTVAF17-COL7A1, CARRYING GENE-THERAPEUTIC DNA VECTOR, METHOD FOR PRODUCTION THEREOF, METHOD FOR INDUSTRIAL PRODUCTION OF GENE-THERAPEUTIC DNA VECTOR [P] . 外国专利： RU2730667C2 . 2020-08-24

机译：基于基因治疗DNA载体VTVAF17的基因治疗DNA载体，携带选自基因组KRT5，KRT14，LAMB3，COL7A1的靶基因，以增加这些靶基因的表达水平，生产方法和用途ESCHERICHIA COLI SCS110-AF / VTVAF17-KRT5或ESCHERICHIA COLI SCS110-AF / VTVAF17-KRT14或ESCHERICHIA COLI SCS110-AF / VTVAF17-LAMB3或ESCHERICHIA COLI SCS110-AF / VTVAF17-PEC7A1，携带DNA-THERA生产其的方法，基因治疗DNA矢量的工业生产方法

相关主题

Crystallization and preliminary crystallographic studies of ribosome recycling factor from Escherichia coli

摘要

著录项

相似文献

相关主题

期刊订阅